A detailed history of Janney Montgomery Scott LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 22,922 shares of CPRX stock, worth $528,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,922
Previous 22,922 -0.0%
Holding current value
$528,122
Previous $355,000 28.45%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$14.68 - $16.92 $1,101 - $1,269
75 Added 0.33%
22,922 $355,000
Q1 2024

May 01, 2024

BUY
$13.18 - $17.11 $487 - $633
37 Added 0.16%
22,847 $364,000
Q4 2023

Feb 07, 2024

SELL
$11.78 - $17.29 $10,013 - $14,696
-850 Reduced 3.59%
22,810 $383,000
Q3 2023

Nov 08, 2023

SELL
$11.69 - $15.02 $5,400 - $6,939
-462 Reduced 1.92%
23,660 $277,000
Q2 2023

Jul 26, 2023

SELL
$11.5 - $18.08 $271,641 - $427,067
-23,621 Reduced 49.48%
24,122 $324,000
Q1 2023

Apr 28, 2023

BUY
$14.34 - $21.05 $70,825 - $103,965
4,939 Added 11.54%
47,743 $792,000
Q4 2022

Feb 01, 2023

BUY
$12.25 - $19.5 $306,642 - $488,124
25,032 Added 140.85%
42,804 $796,000
Q2 2022

Aug 03, 2022

BUY
$6.23 - $8.57 $6,230 - $8,570
1,000 Added 5.96%
17,772 $122,000
Q1 2022

May 04, 2022

BUY
$5.31 - $8.31 $89,059 - $139,375
16,772 New
16,772 $139,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.37B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.